SMITHS FALLS, Ont. — Canopy Growth Corp. has signed a deal to buy a German company that specializes in cannabinoid-based medical therapies used by European physicians for roughly $342.9 million.Under the deal, the Ontario-based company has acquired C3 Cannabinoid Compound Co.C3’s main medicinal offering is dronabinol, a compound with standardized concentrations of THC (tetrahydrocannabinol), the main psychoactive compound in cannabis.Dronabinol is available in Austria, Denmark and Germany.C3 has two manufacturing facilities specializing, respectively, in natural extraction and synthetic cannabinoid production.The company’s senior management team is expected to continue with the business. Companies in this story: (TSX:WEED) The Canadian Press read more
The death toll from the inclement weather rose beyond 90 with over 100 missing, officials said.The Disaster Management Centre said that 91 people have been confirmed killed and 110 missing so far. A majority of those killed were from a landslide in Kalutara and flooding in Ratnapura.Officials said that that adverse weather had badly affected seven districts.
26 May 2020
14 May 2020
14 May 2020
Powered By Impressive Business WordPress Theme